...
首页> 外文期刊>Journal of biomedical science. >Shikonin selectively induces apoptosis in human prostate cancer cells through the endoplasmic reticulum stress and mitochondrial apoptotic pathway
【24h】

Shikonin selectively induces apoptosis in human prostate cancer cells through the endoplasmic reticulum stress and mitochondrial apoptotic pathway

机译:紫草素通过内质网应激和线粒体凋亡途径选择性诱导人前列腺癌细胞凋亡

获取原文
           

摘要

BackgroundDespite the recent progress in screening and therapy, a majority of prostate cancer cases eventually attain hormone refractory and chemo-resistant attributes. Conventional chemotherapeutic strategies are effective at very high doses for only palliative management of these prostate cancers. Therefore chemo-sensitization of prostate cancer cells could be a promising strategy for increasing efficacy of the conventional chemotherapeutic agents in prostate cancer patients. Recent studies have indicated that the chemo-preventive natural agents restore the pro-apoptotic protein expression and induce endoplasmic reticulum stress (ER stress) leading to the inhibition of cellular proliferation and activation of the mitochondrial apoptosis in prostate cancer cells. Therefore reprogramming ER stress-mitochondrial dependent apoptosis could be a potential approach for management of hormone refractory chemoresistant prostate cancers. We aimed to study the effects of the natural naphthoquinone Shikonin in human prostate cancer cells.ResultsThe results indicated that Shikonin induces apoptosis in prostate cancer cells through the dual induction of the endoplasmic reticulum stress and mitochondrial dysfunction. Shikonin induced ROS generation and activated ER stress and calpain activity. Moreover, addition of antioxidants attenuated these effects. Shikonin also induced the mitochondrial apoptotic pathway mediated through the enhanced expression of the pro-apoptotic Bax and inhibition of Bcl-2, disruption of the mitochondrial membrane potential (MMP) followed by the activation of caspase-9, caspase-3, and PARP cleavage.ConclusionThe results suggest that shikonin could be useful in the therapeutic management of hormone refractory prostate cancers due to its modulation of the pro-apoptotic ER stress and mitochondrial apoptotic pathways.Electronic supplementary materialThe online version of this article (doi:10.1186/s12929-015-0127-1) contains supplementary material, which is available to authorized users.
机译:背景尽管最近在筛查和治疗方面取得了进展,但大多数前列腺癌病例最终仍获得了激素难治性和化学耐药性。常规的化学治疗策略在非常高的剂量下仅对这些前列腺癌的姑息治疗有效。因此,前列腺癌细胞的化学敏化可能是增加常规化学治疗剂在前列腺癌患者中疗效的有前途的策略。最近的研究表明,化学预防性天然药物可恢复促凋亡蛋白的表达并诱导内质网应激(ER应激),从而导致前列腺癌细胞中细胞增殖的抑制和线粒体凋亡的激活。因此,重编程ER应激-线粒体依赖性细胞凋亡可能是管理激素难治性化学耐药性前列腺癌的潜在方法。我们旨在研究天然萘醌紫草素在人前列腺癌细胞中的作用。结果结果表明,紫草素通过内质网应激和线粒体功能障碍的双重诱导来诱导前列腺癌细胞的凋亡。紫草素诱导活性氧生成并激活内质网应激和钙蛋白酶活性。而且,添加抗氧化剂减弱了这些作用。紫草素还诱导通过促凋亡Bax的表达增强和Bcl-2抑制,线粒体膜电位(MMP)破坏,随后激活caspase-9,caspase-3和PARP裂解介导的线粒体凋亡途径。结论该结果表明,紫草素可能通过调节促凋亡的ER应激和线粒体的凋亡途径,在激素难治性前列腺癌的治疗中有用。电子补充材料本文的在线版本(doi:10.1186 / s12929-015) -0127-1)包含补充材料,授权用户可以使用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号